Bilcare Ltd

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 April 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Despite a modest rebound over the past two sessions, Bilcare Ltd has slipped to a fresh 52-week low of Rs 51 on 27 Mar 2026, marking a 56.0% decline from its peak of Rs 116 within the last year. This decline contrasts sharply with the broader market, where the Sensex, although down sharply, remains 3.52% above its own 52-week low. The stock’s persistent weakness raises questions about the underlying factors weighing on this micro-cap healthcare services company.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 March 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

While the broader market showed signs of recovery, Bilcare Ltd slipped to a fresh 52-week low of Rs 51.75 on 24 Mar 2026, extending a challenging period for the healthcare services company amid persistent headwinds.

While the broader market has been attempting to stabilise, Bilcare Ltd has continued its downward trajectory, hitting a fresh 52-week low of Rs 52.11 on 23 Mar 2026. This decline contrasts sharply with the recent sector and market movements, underscoring company-specific pressures that have weighed heavily on the stock.

Shares of Bilcare Ltd, a micro-cap player in the Healthcare Services sector, declined sharply to hit a new 52-week low of Rs.53.02 on 17 Mar 2026, marking a significant downturn in the stock’s performance amid ongoing financial and market pressures.

Shares of Bilcare Ltd, a player in the Healthcare Services sector, declined to a fresh 52-week low of Rs.54 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s valuation amid broader market weakness and company-specific factors.

Bilcare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 13 March 2026, providing investors with the latest insights into its performance and prospects.

Shares of Bilcare Ltd, a player in the Healthcare Services sector, declined sharply to hit a new 52-week low of Rs.55 on 9 Mar 2026, marking a significant downturn in the stock’s performance amid broader market pressures and company-specific concerns.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Bilcare Ltd, a player in the Healthcare Services sector, has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of negative trends. Despite the stagnant revenue growth, the company has demonstrated notable improvements in operating margins and cash reserves, prompting a reassessment of its financial outlook.

Bilcare Ltd., a research-based pharmaceutical packaging solutions provider, reported a consolidated net loss of ₹5.95 crores for Q3 FY26, marking a 51.86% sequential deterioration from the previous quarter's loss of ₹12.36 crores. The company's struggles intensified despite marginal revenue growth, with the stock plunging 5.02% to ₹63.00 following the results announcement, reflecting investor concerns about the company's persistent inability to achieve profitability.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 January 2026, providing investors with the latest insights into its performance and outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 January 2026, providing investors with the most recent insights into its performance and outlook.